Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,979 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00982800 | Does Postoperative Gabapentin Reduce Pain, Opioid Consumption and Anxiety and Have a Positive Effect on Health Related Quality of Life After Radical Prostatectomy? | completed | Phase 4 | 60 | Sunnybrook Health Sciences CentreOTHER | 1 | Aug 6, 2010 | clinicaltrials |
| NCT00422708 | Local Anesthesia for Prostate Biopsy | completed | Phase 4 | 243 | Mayo ClinicOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00035997 |
| Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis |
| completed |
| Phase 4 |
| 261 |
| Novartis PharmaceuticalsINDUSTRY |
| 1 |
| Nov 23, 2009 |
| clinicaltrials |
| NCT00199485 | Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate Cancer | completed | Phase 4 | 44 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jul 29, 2008 | clinicaltrials |
| NCT00590213 | Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX(COMART) | completed | Phase 4 | 125 | AstraZenecaINDUSTRY | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00255268 | CMAB vs IMAB in Metastatic Prostate Cancer | withdrawn | Phase 4 | 15 | AstraZenecaINDUSTRY | 1 | Aug 28, 2007 | clinicaltrials |
| NCT00293696 | Casodex/Zoladex Biomarkers in Localised Prostate Cancer | completed | Phase 4 | 30 | Tampere UniversityOTHER | 1 | May 8, 2007 | clinicaltrials |
| NCT00103623 | The Plenaxis® Experience Study | suspended | Phase 4 | 2,000 | PRAECIS Pharmaceuticals Inc.INDUSTRY | 1 | Sep 19, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Aug 6, 2010source: clinicaltrials